Market Place
Sourcing Support
Five Prime trial investigator pleads guilty to $134K insider trading
13 Apr 2022 //
ENDPTS
Five Prime trial investigator pleads guilty to $134K insider trading
12 Apr 2022 //
ENDPTS
DOJ charges former Five Prime trialist with securities fraud
22 Dec 2021 //
ENDPTS
Five Prime founder Rusty Williams sets out to test the limits of cell therapy
13 Sep 2021 //
ENDPTS
Amgen Successfully Completes Acquisition Of Five Prime Therapeutics
17 Apr 2021 //
PRESS RELEASE
Amgen Successfully Completes Acquisition Of Five Prime Therapeutics
16 Apr 2021 //
PRNEWSWIRE
Amgen Successfully Completes Acquisition Of Five Prime Therapeutics
16 Apr 2021 //
PRESS RELEASE
How Amgen Acquired Five Prime for $1.9 Billion, Beating Out a Dozen Others
19 Mar 2021 //
BIOSPACE
Amgen To Acquire Five Prime Therapeutics For $1.9 Billion in Cash
05 Mar 2021 //
PRESS RELEASE
Five Prime to Participate in the Cowen 41st Annual Health Care Conference
26 Feb 2021 //
BUSINESSWIRE
Five Prime Therapeutics phase 2 FIGHT trial evaluating bemarituzumab
18 Jan 2021 //
PHARMABIZ
Phase 2 FIGHT Trial Results Presented at ASCO GI Validate Importance of FGFR2b
15 Jan 2021 //
BUSINESSWIRE
Five Prime finalizes PhIII plans for gastric cancer; AI diagnostics
15 Jan 2021 //
ENDPTS
Five Prime to Present Phase 2 FIGHT Trial Results of Bemarituzumab
09 Dec 2020 //
BUSINESSWIRE
Five Prime to Present Phase 2 FIGHT Trial Results of Bemarituzumab
09 Dec 2020 //
BUSINESSWIRE
Five Prime Announces Bemarituzumab Plus Chemotherapy Demonstrate
10 Nov 2020 //
FIVEPRIME
Spectrum Pharma nabs Five Prime, Gilead vet as clinical lead
04 Jun 2020 //
FIERCE BIOTECH
Five Prime taps Genentech vet Civik to take the helm
14 Apr 2020 //
FIERCE BIOTECH
Five Prime`s Announces Publication of the Phase 1 Bemarituzumab
14 Mar 2020 //
BUSINESSWIRE
Five Prime Therapeutics Announces Publication of the Phase 1 Bemarituzumab Study
14 Mar 2020 //
BUSINESSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.